| RS1868949196 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS186900352 |
ABCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tangier disease, Hypoalphalipoproteinemia |
| RS1869006331 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS186906598 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Cardiovascular phenotype |
| RS186908155 |
MACF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1869082532 |
ERBB3
|
Health Risk |
Pathogenic |
Visceral neuropathy, familial |
| RS186908289 |
SRP72
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant aplasia and myelodysplasia, Familial cancer of breast |
| RS1869112857 |
SACS
|
Health Risk |
Pathogenic |
— |
| RS186911476 |
ABCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tangier disease, Hypoalphalipoproteinemia |
| RS1869136727 |
SACS
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1869146335 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1869162207 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS186916831 |
KMT2E
|
Health Risk |
Conflicting classifications of pathogenicity |
O'Donnell-Luria-Rodan syndrome, See cases |
| RS186924074 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Inborn genetic diseases |
| RS186926737 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS186927032 |
POLR3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukodystrophy, hypomyelinating |
| RS1869287041 |
MIPEP
|
Health Risk |
Likely pathogenic |
Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome, Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome |
| RS1869297835 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS186930123 |
CEP152
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 9, primary |
| RS1869312458 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS1869312922 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS186932188 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Autosomal dominant cerebellar ataxia |
| RS1869351345 |
GJB6
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Hidrotic ectodermal dysplasia syndrome |
| RS186935606 |
GLDN
|
Health Risk |
Conflicting classifications of pathogenicity |
GLDN-related disorder, GLDN-related disorder |
| RS186942072 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1E, Brugada syndrome 1 |
| RS186942296 |
GBE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type IV |
| RS1869458758 |
TNFSF11
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive osteopetrosis 2, Autosomal recessive osteopetrosis 2 |
| RS186945948 |
FOXA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS186946111 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS186946267 |
ALG3
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG3-congenital disorder of glycosylation, ALG3-congenital disorder of glycosylation |
| RS1869502750 |
FREM2
|
Health Risk |
Pathogenic |
Fraser syndrome 2, Fraser syndrome 2 |
| RS186950965 |
NPHP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Inborn genetic diseases |
| RS1869529188 |
TBX5
|
Health Risk |
Pathogenic |
Holt-Oram syndrome, Holt-Oram syndrome |
| RS186952950 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS186953545 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Piebaldism, Mastocytosis |
| RS1869539814 |
TBX5
|
Health Risk |
Pathogenic |
Aortic valve disease 2, Aortic valve disease 2 |
| RS1869545423 |
FREM2
|
Health Risk |
Pathogenic |
Fraser syndrome 2, Fraser syndrome 2 |
| RS1869545659 |
TBX5
|
Health Risk |
Pathogenic/Likely pathogenic |
Aortic valve disease 2, Holt-Oram syndrome |
| RS186956439 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
Larsen syndrome, Larsen syndrome |
| RS1869579851 |
FREM2
|
Health Risk |
Pathogenic |
Fraser syndrome 2, Fraser syndrome 2 |
| RS1869623039 |
FREM2
|
Health Risk |
Pathogenic |
Fraser syndrome 2, Fraser syndrome 2 |
| RS186964660 |
FRAS1
|
Health Risk |
Pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS1869657867 |
GNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-D |
| RS1869683236 |
FREM2
|
Health Risk |
Pathogenic |
Fraser syndrome 2, Fraser syndrome 2 |
| RS186970259 |
CPLANE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 17, Joubert syndrome 17 |
| RS186972208 |
MYOM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS186972495 |
FAM161A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 28, Retinitis pigmentosa 28 |
| RS186972955 |
TMPRSS3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 8, TMPRSS3-related disorder |
| RS1869751155 |
FREM2
|
Health Risk |
Pathogenic |
— |
| RS186975400 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS186979818 |
SLC12A3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1869871757 |
FREM2
|
Health Risk |
Pathogenic |
— |
| RS186987240 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyropoikilocytosis, hereditary |
| RS1869886793 |
FREM2
|
Health Risk |
Likely pathogenic |
Fraser syndrome 2, Fraser syndrome 2 |
| RS186990940 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1, Usher syndrome type 1 |
| RS186992412 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
TTN-related disorder, Early-onset myopathy with fatal cardiomyopathy |
| RS186993093 |
ACOX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Acyl-CoA oxidase deficiency, Acyl-CoA oxidase deficiency |
| RS1869939768 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS1869941124 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS186994154 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyropoikilocytosis, hereditary |
| RS186995249 |
SDHC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pheochromocytoma and paraganglioma, Hereditary cancer-predisposing syndrome |
| RS186997078 |
ATP6V0A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive distal renal tubular acidosis, Autosomal recessive distal renal tubular acidosis |
| RS186998116 |
PIK3CD
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 14, Immunodeficiency 14 |
| RS186999408 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2C, ADGRV1-related disorder |
| RS186999439 |
PIEZO2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arthrogryposis, distal |
| RS187003641 |
CC2D2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel-Gruber syndrome, Meckel syndrome |
| RS187004457 |
CYP4F22
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive congenital ichthyosis 5, Inborn genetic diseases |
| RS187005834 |
LDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency, Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency |
| RS187007187 |
KNL1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1870100373 |
LEMD3
|
Health Risk |
Pathogenic |
Melorheostosis with osteopoikilosis, Inborn genetic diseases |
| RS187011732 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS187013643 |
ABCA12
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1870169267 |
LZTR1
|
Health Risk |
Likely pathogenic |
LZTR1-related disorder, LZTR1-related disorder |
| RS1870200055 |
MED13L
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1870202051 |
MED13L
|
Health Risk |
Pathogenic |
Dextro-looped transposition of the great arteries, Intellectual disability |
| RS1870211191 |
MED13L
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1870221353 |
MED13L
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiac anomalies - developmental delay - facial dysmorphism syndrome, Cardiac anomalies - developmental delay - facial dysmorphism syndrome |
| RS187022757 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS187023993 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 3 |
| RS1870251884 |
SACS
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS187027021 |
GPAA1
|
Health Risk |
Likely pathogenic |
Glycosylphosphatidylinositol biosynthesis defect 15, Glycosylphosphatidylinositol biosynthesis defect 15 |
| RS187027323 |
F13A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor XIII, A subunit |
| RS187028696 |
OPA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Optic atrophy 3, 3-Methylglutaconic aciduria type 3 |
| RS187029293 |
HABP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor VII Marburg I Variant Thrombophilia, Factor VII Marburg I Variant Thrombophilia |
| RS187033414 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
OTOF-related disorder, OTOF-related disorder |
| RS187036839 |
PIGN
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS1870392122 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS187043152 |
ZFPM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tetralogy of Fallot, 46 |
| RS187043211 |
JAK1
|
Health Risk |
Conflicting classifications of pathogenicity |
JAK1-related disorder, JAK1-related disorder |
| RS187046823 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Wilson disease |
| RS187052141 |
LTBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Weill-Marchesani syndrome, Glaucoma 3 |
| RS1870531490 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS187055074 |
SCN4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperkalemic periodic paralysis, 7 conditions |
| RS187055696 |
KLB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS187056670 |
AP5Z1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 48, Hereditary spastic paraplegia |
| RS187063864 |
B4GALT7
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome progeroid type, Ehlers-Danlos syndrome |
| RS1870699640 |
KITLG
|
Health Risk |
Pathogenic |
Waardenburg syndrome, IIa 2F |
| RS187070265 |
PIGB
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 80 |
| RS187075195 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1870762150 |
TBX5
|
Health Risk |
Pathogenic |
Aortic valve disease 2, Aortic valve disease 2 |